Strs Ohio Nurix Therapeutics, Inc. Transaction History

Strs Ohio

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 May 28, 2025	BUY	$18.64 - $28.14 $219,952 - $332,052	11,800 New	11,800 $222,000
Q3 2024 Nov 01, 2024	SELL	$18.93 - $25.69 $319,917 - $434,161	-16,900 Reduced 58.89%	11,800 $264,000
Q2 2024 Aug 05, 2024	BUY	$12.02 - $21.3 $344,974 - $611,310	28,700 New	28,700 $598,000
Q2 2021 Jul 26, 2021	SELL	$24.21 - $35.89 $53,262 - $78,958	-2,200 Closed	0 $0
Q1 2021 Apr 23, 2021	SELL	$26.98 - $50.17 $16,188 - $30,102	-600 Reduced 21.43%	2,200 $68,000
Q3 2020 Dec 14, 2020	BUY	$16.05 - $34.91 $44,940 - $97,747	2,800 New	2,800 $97,000

181

74.4M

56.9K

7.9K

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $589M
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.